News
VALUEREAD2: THE AI-POWERED UNIVERSAL DIAGNOSTIC PLATFORM AT THE POINT OF CARE
At Idneo we are working on the future generation of intelligent Rapid Test Readers for the Medtech sector. Value Read 2, an open platform that allows qualitative and quantitative digital diagnosis of Lateral Flow Test (LFT) through a universal reader device capable of interpreting tests from multiple manufacturers and formats through Artificial Intelligence.
At Idneo we are working on the future generation of intelligent Rapid Test Readers for the Medtech sector. Value Read 2, an open platform that allows qualitative and quantitative digital diagnosis of Lateral Flow Test (LFT) through a universal reader device capable of interpreting tests from multiple manufacturers and formats through Artificial Intelligence.
The Cloud side of the platform allows the development, training and deployment of Artificial Intelligence algorithms in the Reader device as well as its monitoring and traceability of diagnoses.
This project addresses epidemiological, analytical and market needs, combining the speed, simplicity and efficiency of rapid tests with the analytical robustness of more automated diagnostic platforms.
Value Read 2 is co-funded by the European Union – NextGenerationEU.